Aerosol inhalation preparation capable of inhibiting or treating COPD and application thereof
An atomized inhalation agent and atomized inhalation technology, which is applied in respiratory diseases, sulfur/selenium/tellurium active ingredients, drug delivery, etc., to achieve the effects of increasing liver index and spleen index, improving weight loss, and broad clinical application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0028] In the following, the present invention will be further described in detail in combination with examples and accompanying drawings, inhalation of NaHS inhibits the occurrence and development of CS-induced COPD in mice, and this inhibitory effect is related to the regulation of CFTR expression and function. However, the following embodiments are only used to illustrate the purpose of the present invention, and do not limit the protection scope of the present invention.
[0029] 1. Main materials
[0030] 1. Main reagents and consumables for the experiment
[0031] Human airway epithelial cells 16HBE, Shanghai Cell Bank, Chinese Academy of Sciences;
[0032] Sodium hydrosulfide (NaHS), American Sigma company;
[0033] Red Rose brand cigarettes, Guangdong China Tobacco Industry Co., Ltd.;
[0034] Sodium pentobarbital, Guangzhou Chemical Plant No. 2;
[0035] Normal saline, Dongguan Puji Pharmaceutical Co., Ltd.;
[0036] PBS (Phosphate), Geno Biopharmaceutical Co., L...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


